T2 Biosystems, Inc.
TTOO · OTC
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -67.8% | -20.5% | 54.8% | – |
| Gross Profit | -$0 | $0 | $0 | -$0 |
| % Margin | -113.6% | 5.2% | 26.2% | -17.4% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -610% | -246% | -146.6% | -202.5% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -696.2% | -278% | -175.5% | -258.1% |
| EPS Diluted | -19.19 | -1,222.14 | -1,549.82 | -1,928.54 |
| % Growth | 98.4% | 21.1% | 19.6% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |